OptimizeRx Corporation Common Stock (OPRX)

Price$5.38

Value ScoreB

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-77.71%

Price vs S&P 500 (4W)-27.51%

VGM Score50.83

Market Capitalization$97.39M

P/E Ratio (Annual)18.98x

All Metrics

P/CF (Annual)5.20x

Book Value / Share (Quarterly)$6.91

P/TBV (Annual)2.61x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)20.56%

Cash Flow / Share (Quarterly)$0.77

Price vs S&P 500 (YTD)-68.60%

Gross Margin (TTM)70.04%

Net Profit Margin (TTM)6.37%

EPS (TTM)$0.36

10-Day Avg Trading Volume0.45M

EPS Excl Extra (TTM)$0.36

Revenue Growth (5Y)20.37%

EPS (Annual)$0.27

ROI (Annual)3.33%

Gross Margin (Annual)67.25%

Net Profit Margin (5Y Avg)-11.88%

Cash / Share (Quarterly)$1.07

P/E Basic Excl Extra (TTM)14.25x

Revenue Growth QoQ (YoY)-9.50%

P/E Normalized (Annual)18.98x

ROA (Last FY)2.90%

Revenue Growth TTM (YoY)13.75%

EBITD / Share (TTM)$1.50

ROE (5Y Avg)-7.17%

Operating Margin (TTM)13.23%

Cash Flow / Share (Annual)$1.00

P/B Ratio0.75x

P/B Ratio (Quarterly)0.91x

Net Income / Employee (Annual)$49,300

EV / Revenue (TTM)0.94x

Net Interest Coverage (TTM)2.41x

ROA (TTM)4.00%

EV / EBITDA (TTM)3.53x

EPS Incl Extra (Annual)$0.27

Current Ratio (Annual)3.04x

Quick Ratio (Quarterly)5.07x

3-Month Avg Trading Volume0.49M

52-Week Price Return-56.93%

EV / Free Cash Flow (Annual)5.35x

P/E Incl Extra (TTM)14.25x

Revenue / Employee (TTM)$1,032,200

Tangible BV / Share (Quarterly)$4.79

P/S Ratio (Annual)0.89x

Asset Turnover (Annual)0.62x

52-Week High$22.25

Operating Margin (5Y Avg)-12.04%

EPS Excl Extra (Annual)$0.27

CapEx CAGR (5Y)-22.31%

Tangible BV CAGR (5Y)18.28%

26-Week Price Return-61.78%

Quick Ratio (Annual)2.91x

13-Week Price Return-33.80%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)5.37x

Enterprise Value$100.56M

Revenue / Share Growth (5Y)14.55%

Asset Turnover (TTM)0.63x

Book Value / Share Growth (5Y)15.81%

Revenue / Employee (Annual)$1,052,200

Pretax Margin (Annual)6.35%

Cash / Share (Annual)$1.25

3-Month Return Std Dev78.50%

Gross Margin (5Y Avg)62.45%

Net Income / Employee (TTM)$65,700

EBITDA Interim CAGR (5Y)60.17%

ROE (Last FY)4.00%

Net Interest Coverage (Annual)2.99x

EPS Basic Excl Extra (Annual)$0.27

P/FCF (TTM)5.18x

Receivables Turnover (TTM)3.32x

EV / Free Cash Flow (TTM)6.93x

Total Debt / Equity (Quarterly)0.18x

EPS Incl Extra (TTM)$0.36

Receivables Turnover (Annual)2.88x

ROI (TTM)4.52%

P/S Ratio (TTM)0.91x

Pretax Margin (5Y Avg)-13.51%

Revenue / Share (Annual)$5.76

Tangible BV / Share (Annual)$4.66

Forward P/E6.73x

Price vs S&P 500 (52W)-85.14%

P/E Ratio (TTM)14.25x

Year-to-Date Return-57.67%

5-Day Price Return5.06%

EPS Normalized (Annual)$0.27

ROA (5Y Avg)-5.33%

Net Profit Margin (Annual)4.69%

Month-to-Date Return-16.69%

Cash Flow / Share (TTM)$-0.70

EBITD / Share (Annual)$0.84

Operating Margin (Annual)10.69%

LT Debt / Equity (Annual)0.17x

P/CF (TTM)6.77x

ROI (5Y Avg)-5.93%

P/E Excl Extra (TTM)14.25x

LT Debt / Equity (Quarterly)0.16x

EPS Basic Excl Extra (TTM)$0.36

P/TBV (Quarterly)1.31x

P/B Ratio (Annual)1.78x

Pretax Margin (TTM)8.93%

Book Value / Share (Annual)$6.84

Price vs S&P 500 (13W)-43.55%

Beta1.10x

P/FCF (Annual)5.18x

Revenue / Share (TTM)$5.72

ROE (TTM)5.47%

52-Week Low$4.57

vGradeB

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.14est. 0.00

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.15

Industry Peers — Business Services(116)

Symbol	Value Score	Growth Score	Momentum Score	Price
OPRXOptimizeRx Corporation Common Stock	B	C	D	$5.38
VVISA Inc.	D	C	C	$322.77
MAMastercard Incorporated	D	B	C	$495.25
UBERUber Technologies, Inc.	C	C	C	$73.77
ACNAccenture PLC	B	C	D	$196.59
MELIMercado Libre, Inc	C	B	C	$1730.98
DASHDoorDash, Inc. Class A Common Stock	D	B	C	$164.78
RELXRELX PLC	D	C	C	$34.60
EBAYeBay Inc	D	D	B	$110.35
MSCIMSCI, Inc.	D	C	B	$643.83
BABAAlibaba Group Holding Limited American Depositary Shares, each represents eight Ordinary Shares	C	D	C	$125.40

About

OptimizeRx provides a cloud-based digital health messaging platform integrated with electronic health records that enables pharmaceutical companies to communicate directly with healthcare providers and patients. The platform supports medication adherence through real-time access to financial assistance, prior authorization, clinical information, and patient education. Its product suite includes Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.